CBS 2019
CBSMD教育中心
中 文

血管内超声指导

Abstract

Recommended Article

Consensus from the 5th European Bifurcation Club meeting Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial) Results From the OPINION Imaging Study Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes

JOURNAL:CBS2017 Article Link

PADN绽放在ESC2017

CBS2017


ESC2017盛大开幕!




欧洲心脏病学会(European Society of Cardiology)2017届年会于当地时间8月26日上午8点半(北京时间26日下午14点半)盛大开幕,全球3万多医生及医疗工作者汇聚西班牙巴塞罗那参加此次盛会。ESC由来自全球56个国家级心脏学会医疗专家志愿者组成,现有成员95000名,27个专科分会,43个附属心脏学会。





本次ESC大会发布了双抗治疗、急性ST段抬高型心肌梗死(ST segment elevation myocardial infarction, STEMI) 、外周动脉疾病(Peripheral Arterial Diseases)及心脏瓣膜疾病(Valvular Heart Disease)四个方面的最新循证医学依据的诊治指南。点击此处详细阅读相关最新指南内容。





27日上午,陈绍良教授在ESC大会现场做了围绕肺动脉高压的介入治疗、机制及疗效的“肺动脉高压介入治疗”专题学术报告。陈绍良教授创新性提出通过肺动脉去神经术治疗肺动脉高压。迄今,该技术已在中国、美国、俄罗斯等国家广泛推广应用,为肺动脉高压这个世界性难题提供了新的治疗方向及策略,给患者带来希望。


肺动脉高压(PAH)一直属于世界性难题,一部分患者无法从单药治疗甚至多联靶向药物治疗中获益,治愈率低、死亡率高、卫生费用高。近年来,随着对心功能不全继发PH的认识深入,寻找更加积极有效的非药物治疗迫在眉睫。陈绍良教授团队创新的经皮肺动脉去神经术(PADN)改变了这一局面。在本次ESC论坛上,陈绍良教授分享了团队从动物实验入手,验证PADN术的有效性和安全性,直至开展临床研究的发展历程。


8月28日,巴黎时间9点-10点巴塞罗那厅-ESC2017第26会场,陈绍良教授将就冠脉介入治疗做专题学术报告,让我们共同拭目以待。


此行,陈绍良教授将在ESC大会上着重宣传即将于11月30日在中国·南京召开的CBS2017大会。作为左主干、冠脉分叉病变领域的前沿大会,CBS一直秉持开放交流、造福世界的理念,为全球患者获益而持续努力。